Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $584.26 | 20 | 95.9% |
| Education | $24.99 | 1 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $266.65 | 16 | $0 (2023) |
| AbbVie Inc. | $172.11 | 2 | $0 (2021) |
| Gilead Sciences, Inc. | $121.07 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $24.99 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $24.43 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $154.74 | 2 | Gilead Sciences, Inc. ($121.07) |
| 2022 | $20.88 | 1 | ViiV Healthcare Company ($20.88) |
| 2021 | $256.14 | 13 | ViiV Healthcare Company ($149.89) |
| 2020 | $42.21 | 2 | ViiV Healthcare Company ($42.21) |
| 2019 | $20.00 | 1 | ViiV Healthcare Company ($20.00) |
| 2018 | $115.28 | 2 | AbbVie, Inc. ($90.29) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $121.07 | General |
| Category: HCV | ||||||
| 02/02/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: HIV | ||||||
| 10/25/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: HIV | ||||||
| 08/25/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: HIV | ||||||
| 08/24/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: HIV | ||||||
| 07/29/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: HIV | ||||||
| 07/28/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $81.82 | General |
| Category: VIROLOGY | ||||||
| 07/22/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: HIV | ||||||
| 06/17/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: HIV | ||||||
| 05/26/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: HIV | ||||||
| 05/06/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: HIV | ||||||
| 05/06/2021 | ViiV Healthcare Company | DOVATO (Drug), RUKOBIA | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: HIV | ||||||
| 04/08/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: HIV | ||||||
| 04/08/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: HIV | ||||||
| 04/01/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/30/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: HIV | ||||||
| 04/24/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: HIV | ||||||
| 03/09/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: HIV | ||||||
| 08/21/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: HIV | ||||||
| 03/28/2018 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $90.29 | General |
| Category: Virology | ||||||
| 01/31/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $24.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 19 | $614.00 | $180.88 |
| 2022 | 3 | 40 | 61 | $8,683 | $3,314 |
| 2021 | 5 | 68 | 91 | $9,009 | $3,618 |
| 2020 | 3 | 53 | 78 | $6,505 | $2,632 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 19 | $614.00 | $180.88 | 29.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 22 | $4,730 | $1,835 | 38.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,113 | $1,211 | 38.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 28 | $840.00 | $268.32 | 31.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 19 | $4,085 | $1,633 | 40.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 26 | $3,874 | $1,550 | 40.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 16 | 23 | $690.00 | $223.33 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $360.00 | $212.66 | 59.1% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 11 | 11 | $0.11 | $0.11 | 100.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 35 | $5,215 | $2,085 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 15 | 17 | $510.00 | $298.31 | 58.5% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 21 | 26 | $780.00 | $249.23 | 32.0% |
About Dr. Vinod Thomas, MD
Dr. Vinod Thomas, MD is a Infectious Disease healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1598995045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vinod Thomas, MD has received a total of $609.25 in payments from pharmaceutical and medical device companies, with $154.74 received in 2023. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($584.26).
As a Medicare-enrolled provider, Thomas has provided services to 175 Medicare beneficiaries, totaling 249 services with total Medicare billing of $9,746. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine
- Location Providence, RI
- Active Since 07/17/2009
- Last Updated 04/26/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598995045
Products in Payments
- DOVATO (Drug) $224.58
- Epclusa (Drug) $121.07
- Mavyret (Drug) $90.29
- MAVYRET (Drug) $81.82
- SYMTUZA (Drug) $24.43
- CABENUVA (Biological) $21.19
- APRETUDE (Biological) $20.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Providence
Kenneth Mayer, M.d, M.D
Infectious Disease — Payments: $215,232
Angela Caliendo, M.d., Ph.d, M.D., PH.D
Infectious Disease — Payments: $74,183
Timothy Flanigan, Md, MD
Infectious Disease — Payments: $57,834
Maria Mileno, Md, MD
Infectious Disease — Payments: $9,583
Rami Kantor, M.d, M.D
Infectious Disease — Payments: $8,643
Susan Cu Uvin, Md, MD
Infectious Disease — Payments: $7,364